MVM invested $15 million in InBrace. InBrace is an orthodontic company that created the novel SmartwireTM, a new category in teeth straightening. Teeth straightening is a $40 billion market opportunity served primarily by two types of treatment: traditional bracket-and-wire braces and clear aligners. However, both options create aesthetic concerns for patients and clear aligners further rely on patient compliance. Due to these challenges, a large majority of patients choose not to get treated.

Based in Irvine, CA, InBrace sells an innovative bracket-and-wire approach that is functionally invisible because of its placement on the back of the teeth. This gives patients a new treatment option that addresses the aesthetic and compliance shortcomings of existing products, and offers orthodontists a professional-only product to differentiate and grow their practices.

Latest news

Paragon 28, Inc. Announces Pricing of Initial Public Offering
October 15, 2021

ENGLEWOOD, Colo., Oct. 15, 2021 /PRNewswire/ — Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and […]

Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate
August 6, 2021

Saint Herblain (France), August 5, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the […]

Vertos mild® Patients Demonstrate Durable 5 Year Outcomes
May 18, 2021

Most Minimally Invasive Lumbar Decompression (mild®) providers are very familiar with the 1-year study conducted by Nagy Mekhail, MD, PhD […]

Valneva Announces the Pricing of its Initial Public Offering on Nasdaq
May 11, 2021

Saint-Herblain (France), May 6, 2021  – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for […]

eXmoor pharma secures £12m ($17m) from healthcare investment firm MVM marking milestone towards significant expansion plans
March 16, 2021

eXmoor, the expert cell and gene therapy (CGT) services company (Bristol, England), has announced an initial investment of £12m ($17m) […]

Hologic announces acquisition of Biotheranostics
January 5, 2021

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has agreed to acquire Biotheranostics, Inc., […]

MVM invests in GT Medical
November 23, 2020

GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced it has […]

MVM invests in Paragon 28
August 15, 2020

Paragon 28, Inc., a leading orthopedic foot and ankle company, today announced the completion of a Series B financing. The […]

MDxHealth Announces Growth Investment from MVM Partners
May 18, 2020

Press release Regulated information – Inside information IRVINE, CA, and HERSTAL, BELGIUM – 27 April 2020 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” […]

MVM leads investment round in SkyCell
May 4, 2020

In April 2020, MVM led the growth investment round in SkyCell, a company that has developed patented temperature-control technology to […]